Docturnal Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.12 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -13.44%
- Profit Growth 67.21%
- Ebitda 79.80%
- Net Worth -110.98%
- Total Assets 15.54%
About Docturnal
Docturnal Private Limited (DPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 29 April 2016 (Eight years and nine months 5 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Balakrishna Bagadi, Vaishnvi Reddy, Arpita Singh, and One other member serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U85190TG2016PTC109301
-
Company No.
109301
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Apr 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Docturnal?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balakrishna Bagadi
|
Director | 29-Apr-2016 | Current |
|
Vaishnvi Reddy
|
Director | 25-Oct-2018 | Current |
|
Arpita Singh
|
Director | 05-Nov-2019 | Current |
|
Rahul Pathri
|
Director | 29-Apr-2016 | Current |
Financial Performance of Docturnal.
Docturnal Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 13.44% decrease. The company also saw a substantial improvement in profitability, with a 67.21% increase in profit. The company's net worth observed a substantial decline by a decrease of 110.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Docturnal?
In 2021, Docturnal had a promoter holding of 96.63% and a public holding of 3.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Signel Biomedical Private LimitedVaishnvi Reddy is a mutual person
-
Builtiful Homes And Buildings Private LimitedVaishnvi Reddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Docturnal?
Unlock and access historical data on people associated with Docturnal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Docturnal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Docturnal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
